MacroGenics Investor Relations Material
Latest events
Q4 2024
MacroGenics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from MacroGenics Inc
Access all reports
MacroGenics Inc. is a biopharmaceutical company focused on developing and commercializing antibody-based therapies for the treatment of cancer and other serious diseases. The company's pipeline includes immuno-oncology therapies designed to harness the immune system to target and destroy cancer cells. MacroGenics employs its proprietary antibody platforms to create innovative treatments that address unmet medical needs in oncology and other therapeutic areas. The company is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.
Key slides for MacroGenics Inc
Study Update
MacroGenics Inc
Study Update
MacroGenics Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
MGNX
Country
🇺🇸 United States